Viaminate
CAS: 53839-71-7
Ref. 3D-DCA83971
| 1g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
- N-(4-Ethoxycarbophenyl)retinamide
- N-(p-Ethoxycarbonylphenyl)retinamide
- N-[4-(Ethoxycarbonyl)phenyl]retinamide
- Retinamide, N-[4-(ethoxycarbonyl)phenyl]-
Viaminate is a small-molecule drug that targets the symptoms of squamous cell carcinoma. It has been shown to be effective against solid tumours, including squamous cell carcinomas, and is an antagonist of TNF-α. Viaminate inhibits the growth of tumor cells by binding to their receptors for epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α). It also suppresses the production of TNF-α. This compound has been shown to inhibit tumor cells in vitro and in vivo, with no significant side effects.
Propiedades químicas
Consulta técnica sobre: 3D-DCA83971 Viaminate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
